Certara

Certara, Critical Path Institute partner

Wednesday, September 11, 2013 01:33 PM

Certara, a provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, is partnering with the independent nonprofit Critical Path Institute (C-Path) to develop a physiologically-based pharmacokinetic (PBPK) model of the human lung.

More... »

Certara releases version 13 of Simcyp Simulator

Wednesday, August 28, 2013 12:37 PM

Certara, a provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through development, has released version 13 of its Simcyp Simulator, which permits the quantitative prediction of drug-drug interactions and pharmacokinetic-pharmacodynamic outcomes in virtual populations.

More... »

Certara acquires Great Lakes Drug Development

Thursday, August 15, 2013 10:11 AM

Certara, a provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, has acquired drug development consultancy Great Lakes Drug Development (GLDD), based in Brighton, Mich. Both companies focus on pharmacokinetic (PK) and pharmacodynamic (PD) analysis, project management and pharmacometric modeling and simulation. GLDD focuses on early development work, while Certara’s products and services span the entire drug development continuum.

More... »

Certara launches Cardiac Safety Simulator

Thursday, August 1, 2013 09:30 AM

St. Louis-based Certara, a provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, has launched its Cardiac Safety Simulator (CSS), based on an in-silico model of human ventricular heart cells.

More... »

Certara, Veristat partner for combined service offerings

Tuesday, May 14, 2013 01:37 PM

Certara, a provider of software and scientific consulting services from drug discovery through clinical development, and Veristat, a full-service CRO, have formed an alliance to offer combined services to their clients.

More... »

Certara acquires Simcyp, adding preclinical research capability

Thursday, March 1, 2012 11:00 AM

Certara, a provider of drug discovery and development software and scientific consulting services, will acquire U.K-based Simcyp, a research company providing a modeling and simulation platform for predicting the fate of drugs in virtual populations.

More... »